Zobrazeno 1 - 10
of 143
pro vyhledávání: '"Arpaci E"'
Publikováno v:
Architectural Engineering & Design Management; Apr2024, Vol. 20 Issue 2, p320-336, 17p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Oktay, E, Levent, M, Gelincik, H, Aktas, G, Yumuk, F, Koral, L, Arpaci, E, Keser, M, Alkan, A, Karci, E, Karadurmus, N, Degirmencioglu, S, Turan, M, Uyeturk, U, Cabuk, D, Avci, N, Toprak, O, Ergen, A, Urvay, S, Bayman, E, Petekkaya, E, Nayir, E, Paydas, S, Yavuzsen, T, Senler, FC, Yaren, A, Barutca, S, Sahinler, I, Ozyilkan, O, Tanriverdi, O
Cancer is one of the most common causes of death all over the World (Rahib et al. in Cancer Res 74(11):2913-2921, 2014; Silbermann et al. in Ann Oncol 23(Suppl 3):iii15-iii28, 2012). It is crucial to diagnose this disease early by effective screening
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::d790adf30823fe7b00c4e16ea36a586b
Autor:
Degirmencioglu, S, Tanriverdi, O, Menekse, S, Dogan, M, Hacioglu, B, Oktay, E, Erdem, D, Arpaci, E, Uluc, BO, Turhal, S, Yilmaz, M, Pilanci, KN, Sakin, A, Araz, M, Cokmert, S, Ozdemir, O, Sen, E, Nayir, E
Purpose: To compare the efficacy and adverse effect profiles of the first-line treatment of patients with KRAS wild type metastatic colorectal cancer (CRC) in Turkey who were treated based on regimens including bevacizumab, cetuximab and panitumumab.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::6fa15f0adedeb7889edaa614f999923b
Purpose: To compare the efficacy and adverse effect profiles of the first-line treatment of patients with KRAS wild type metastatic colorectal cancer (CRC) in Turkey who were treated based on regimens including bevacizumab, cetuximab and panitumumab.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______9718::e8719b988359513d5aaaf1aa140af79f
http://hdl.handle.net/20.500.12481/11950
http://hdl.handle.net/20.500.12481/11950
Autor:
Suner, A., Aydin, D., Bekir Hacioglu, Dogu, G. G., Imamoglu, G. I., Menekse, S., Pilanci, K. N., Yazici, O. K., Koca, D., Karaagac, M., Akyol, M., Akman, T., Ergen, S., Avci, N., Kacan, T., Bozkurt, O., Kefeli, U., Urakci, Z., Araz, M., Arpaci, E., Harputlu, H., Sevinc, A.
Publikováno v:
Web of Science
WOS: 000376904300006
PubMed ID: 27097941
OBJECTIVE: Prostate cancer is among the most common cancers in males. Prostate cancer is androgen dependent in the beginning, but as time progresses, it becomes refractory to androgen deprivation tre
PubMed ID: 27097941
OBJECTIVE: Prostate cancer is among the most common cancers in males. Prostate cancer is androgen dependent in the beginning, but as time progresses, it becomes refractory to androgen deprivation tre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::087d9b64aee278174bbb87cd3212c72d
https://hdl.handle.net/20.500.12418/7398
https://hdl.handle.net/20.500.12418/7398
Central nervous system (CNS) metastasis is a rare event in the course of late stage epithelial ovarian cancer (EOC); however its incidence is increasing in parallel with prolonged survival of patients. Objective: The authors assessed the clinical par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::129c4b58e5475ed96693b6e52181ecac
https://hdl.handle.net/11499/9312
https://hdl.handle.net/11499/9312
Purpose: To evaluate the efficacy and adverse events with cetuximab plus FOLFOX administered as second- and third-line therapy in metastatic colorectal cancer (mCRC) patients. Methods: IPatients were administered cetuximab plus FOLFOX as second- and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3105::384b443c18a0c392e45d18af8aca10bf
https://hdl.handle.net/20.500.12628/5548
https://hdl.handle.net/20.500.12628/5548
Autor:
Seber, S, Turkmen, E, Harputoglu, H, Yesil, H, Arpaci, E, Menekse, S, Pilanci, K, Oruc, Z, Taskoylu, BY, Gumusay, O, Aksoy, A, Karaagac, M, Ozarslan, E, Yetisyigit, T
Central nervous system (CNS) metastasis is a rare event in the course of late stage epithelial ovarian cancer (EOC); however its incidence is increasing in parallel with prolonged survival of patients. Objective: The authors assessed the clinical par
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3566::4e07a854473adf2d4af5320ab4915bb1
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/16187
http://acikerisim.pau.edu.tr:8080/xmlui/handle/11499/16187